Armistice Capital’s Voyager Therapeutics VYGR Stock Holding History

Armistice Capital’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$14.9M	Sell	4,800,000 -636,000	-12%	-$1.98M	0.26%	48
2025 Q1	$18.4M	Buy	5,436,000 +40,000	+0.7%	+$135K	0.28%	65
2024 Q4	$30.6M	Buy	5,396,000 +196,000	+4%	+$1.11M	0.42%	43
2024 Q3	$30.4M	Hold	5,200,000	–	–	0.49%	34
2024 Q2	$41.1M	Buy	5,200,000 +528,000	+11%	+$4.18M	0.52%	30
2024 Q1	$43.5M	Buy	4,672,000 +436,000	+10%	+$4.06M	0.58%	26
2023 Q4	$35.8M	Buy	4,236,000 +58,000	+1%	+$490K	0.49%	33
2023 Q3	$32.4M	Buy	4,178,000 +554,000	+15%	+$4.29M	0.5%	36
2023 Q2	$41.5M	Buy	3,624,000 +100,000	+3%	+$1.15M	0.6%	36
2023 Q1	$27.2M	Buy	3,524,000 +128,000	+4%	+$987K	0.39%	48
2022 Q4	$20.7M	Hold	3,396,000	–	–	0.36%	49
2022 Q3	$20.1M	Buy	3,396,000 +832,000	+32%	+$4.93M	0.35%	57
2022 Q2	$15.2K	Buy	2,564,000 +564,000	+28%	+$3.33K	0.26%	68
2022 Q1	$15.2M	Buy	+2,000,000	New	+$15.2M	0.29%	63
2021 Q4	–	Sell	-3,716,000	Closed	-$9.77M	–	178
2021 Q3	$9.77M	Hold	3,716,000	–	–	0.17%	89
2021 Q2	$15.3M	Hold	3,716,000	–	–	0.27%	73
2021 Q1	$17.5M	Buy	3,716,000 +324,000	+10%	+$1.53M	0.4%	61
2020 Q4	$24.3M	Buy	3,392,000 +692,000	+26%	+$4.95M	0.82%	35
2020 Q3	$28.8M	Buy	2,700,000 +622,000	+30%	+$6.64M	1.05%	34
2020 Q2	$26.2M	Sell	2,078,000 -158,000	-7%	-$1.99M	1.15%	34
2020 Q1	$20.5M	Buy	2,236,000 +612,000	+38%	+$5.6M	1.27%	32
2019 Q4	$22.7M	Buy	1,624,000 +528,000	+48%	+$7.37M	1.31%	23
2019 Q3	$18.9M	Buy	1,096,000 +160,000	+17%	+$2.75M	1.25%	27
2019 Q2	$25.5M	Sell	936,000 -600,000	-39%	-$16.3M	1.61%	18
2019 Q1	$29.4M	Sell	1,536,000 -1,300,000	-46%	-$24.9M	1.61%	18
2018 Q4	$26.7M	Buy	2,836,000 +1,112,000	+65%	+$10.5M	2.02%	13
2018 Q3	$32.6M	Buy	1,724,000 +1,292,000	+299%	+$24.4M	1.96%	13
2018 Q2	$8.44M	Buy	+432,000	New	+$8.44M	0.55%	43